Paydirt
CH
Insider

Charles J Homcy

Director · BridgeBio Pharma

Charles J Homcy (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $13.9M of BBIO (300,000 sh across 3 lots, as filed), executed Aug 8 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.9M
shares × price, as filed
Last traded
Aug 11 2025
Filed Aug 12 2025

Median ADV $293.8M across their filed names

Open performance→
Volume by month
$13.9M$7.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2025 · sells $13.9M
Buys $0 Sells $13.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names
BBIO BridgeBio Pharma, Inc. BBIO · 0 buys · 1 sell 1 filing
Recent filings
BBIOSALE BridgeBio Pharma, Inc. View filing → $13.9M
300,000 sh across 3 lots
Exec Aug 8 2025
Filed Aug 12 2025 · 5:30 PM ET